Clinical Trial

Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers. 2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .
Trial Details
NCT Number NCT07383805
Lead Sponsor Assiut University
Conditions Ankylosing Spondylitis, AS, Tim3
Enrollment 81 participants
Start Date 2026-06-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-03